Multispecialty Archive

A building with a stone facade displays a sign that reads
Scott Sholem, D.O., F.A.C.S
A building with a stone facade displays a sign that reads
Paramvir Sidhu, M.D.
A building with a stone facade displays a sign that reads
Mark A. Slater, Ph.D.
A building with a stone facade displays a sign that reads
Helen A. Markowski, M.D., F.A.C.S., CWSP
A building with a stone facade displays a sign that reads
PHASE 1B RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF COR-1389 ON CARDIOPULMONARY HEMODYNAMICS IN PATIENTS WITH PULMONARY HYPERTENSION ASSOCIATED WITH LEFT-HEART DISEASE (PH-LHD)
A building with a stone facade displays a sign that reads
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
A building with a stone facade displays a sign that reads
A Phase 2, Double-blind, Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of TX000045 After 24 Weeks of Treatment in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (PH-HFpEF)
Michael D Beaver
A building with a stone facade displays a sign that reads
A Phase 2, Double-blind, Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of TX000045 After 24 Weeks of Treatment in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (PH-HFpEF)
A building with a stone facade displays a sign that reads
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate The Efficacy And Safety of Belimumab Administered Subcutaneously in Adults With Systemic Sclerosis Associated Interstitial Lung Disease (SSC-ILD)